PRESIDENT Honda Chiu,S&T BioMed CO., LTD.

S&T BioMed CO., LTD.

Prisma Biotech

1.) Single cell Sequencing
2.) Oncology
3.) Microbiome

PRO YANG ENTERPRISE CO.,LTD

movinglife ATTO MOBILITY SCOOTER from Israel
EXGEL premium comfort cushion from Japan

ProtectLife International Biomedical Inc.

ENNOLIFE COVID-19 Antigen Test has to be used with ENNOLIFE Clinical Chemistry Analyzer. The product employs immunomagnetic assay and microfluidic design that is used with analyzer of full-spectrum, and it could detect 3 samples for COVID-19 antigen (nucleocapsid protein) in 25-30 minutes (including pretreatment). It applies to early detection of COVID-19 infected.
According to previous studies, most patients infected with COVID-19 also suffer from other chronic diseases, such as hepatitis, nephritis, cardiovascular disease, diabetes and so on. The ENNOLIFE clinical chemical analyzer not only detects the antigen of COVID-19 but also markers of other chronic diseases. It could achieve multiple diagnosis in one machine.

Protectlife International Biomedical Inc.

ENNOLIFE COVID-19 Antigen Test has to be used with ENNOLIFE Clinical Chemistry Analyzer. The product employs immunomagnetic assay and microfluidic design that is used with analyzer of full-spectrum, and it could detect 3 samples for COVID-19 antigen (nucleocapsid protein) in 25-30 minutes (including pretreatment). It applies to early detection of COVID-19 infected.

According to previous studies, most patients infected with COVID-19 also suffer from other chronic diseases, such as hepatitis, nephritis, cardiovascular disease, diabetes and so on. The ENNOLIFE clinical chemical analyzer not only detects the antigen of COVID-19 but also markers of other chronic diseases. It could achieve multiple diagnosis in one machine.

provitaebio

Pro_Screen

PURIBLOOD MEDICAL CO, LTD

PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)’. Through ZISC technology, our products provide better and stable filtration performance, which can remove more than 99.99% of white blood cells and reduce filtration time. Our product includes:
(A) "Puriblood" Leukocyte reduction filter for red blood cells
(B) "Devin" Microbio enrichment filter
(C) "MiniPuri" Syringe filter for leuko-reduction of PRP

PuriBlood, in conjunction with RDCMT, holds over 36+ patents supporting our core membrane technology. Our partners include known international group and exceptional clinician. We aim for bringing the world a safer way in transfusion and cell therapy.